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the first measures. If recurrent urinary tract infections or OPN 
occur, long-term follow-up and low-dose antibiotic prophy-
laxis may be discussed.  © 2015 S. Karger AG, Basel 
 Introduction 
 Renal obstruction arises most often from urolithiasis, 
tumors, pregnancy, scars after infection or trauma, con-
genital anomalies, or operations. End-stage renal ob-
struction with loss of parenchyma but without infection 
is termed hydronephrosis  [1] . An infection in an ob-
structed kidney is a severe form of complicated urinary 
tract infection (UTI). After loosing renal function and pa-
renchyma, an infected and obstructed kidney may be 
termed ‘pyonephrosis’, if there is pus within the dilated 
collecting system (‘pus under pressure’)  [2, 3] . The transi-
tion between the two forms might be gradual. All infec-
tions in obstructed kidneys should be considered compli-
cated pyelonephritis with obstruction or obstructive py-
elonephritis (OPN).
 The main causative bacteria in OPN are E. coli, Pro-
teus, Klebsiella, or Pseudomonas species  [4–7] . After 
sampling for bacteriological cultures, empiric antibiotic 
therapy needs to be started immediately, and resolving 
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 Abstract 
 Introduction: To evaluate therapeutic results till 5 years after 
therapy of obstructive pyelonephritis (OPN) emphasizing 
regular follow-up.  Material and Methods: During 5 years, 57 
patients with OPN were treated. The patients’ charts were 
reviewed retrospectively for clinical data. These were com-
pleted by a questionnaire.  Results: In the group of 57 pa-
tients (average age 56 years), about two third were women. 
Urolithiasis (65%) and tumors (21%) were the main causes of 
obstruction; fever (91%) and loin pain (86%) the main symp-
toms. Three fourth of the patients showed renal insufficiency 
and nearly 50% anemia.  E. coli and Proteus spp. were the 
dominating organisms. Sonography detected obstruction in 
93% cases. In one third of cases, CT scan was added; 81% 
percutaneous nephrostomy and 19% ureteral stenting were 
the initial methods of urinary drainage. During therapy, 23% 
nephrectomies (19% complete, 4% partial) were performed. 
Long-term follow-up showed 11% recurrent OPN and 33% 
recurrent UTI.  Conclusions: After diagnosis of OPN, primary 
nephrostomy or ureteral stenting and antibiotic therapy are 
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the obstruction under antibiotic therapy is mandatory  [3, 
5, 7] .
 Long-term follow-up data after antibiotic therapy and 
relief of renal obstruction of OPN are widely missing for 
adults.
 Materials and Methods 
 The data of all patients with OPN at the Department of Urol-
ogy, University of Munich, needing inpatient treatment and uri-
nary diversion due to clinical signs, symptoms, and findings dur-
ing a period of 5 years were analyzed retrospectively by reviewing 
the intervention charts for nephrostomy and ureteral stenting. Pa-
tients with manifest urosepticemia at admission were ruled out. 
History, symptoms, laboratory values, imaging results, and thera-
py were included in the review.
 These data were supplemented by a questionnaire sent to the 
family doctor 1–5 years after the hospital stay. All patients agreed 
to participate in the study.
 Results 
 During a period of 5 years, 57 patients (38 women – 
67%, 19 men – 33%) with OPN were identified. The aver-
age age was 56 (range 9–86) (52.0 in women, 64.0 in men), 
and 2/3 were women. The causes of obstruction are shown 
in  table 1 . The average age for patients with OPN due to 
urolithiasis (n = 37, 65%), the most common cause was 
56.6 years and with tumors of the pelvic and retroperito-
neal region (n = 12, 21%), the second most common cause 
was 65.4 years.
 One iatrogenic renal obstruction resulted from double 
J stenting after iatrogenic ureter lesion. The other oc-
curred as a recurrence after Anderson-Hynes pyeloplasty. 
One malformation was an obstructed and deformed single 
kidney, and the other was an obstructed renal duplication.
 The main symptoms were fever (91%) and loin pain 
(86%) (for details, see  table  2 ). Fifty-three out of fifty-
seven patients (93%) showed renal beds sensitive to 
 percussion, whereas one (2%) showed a palpable flank 
 tumor.
 As expected, leucocytosis was the predominant labora-
tory deviation, whereas accelerated blood sedimentation 
rate occurred in only 16%. CRP and procalcitonine were 
not estimated regularly and are therefore not included.
 Overall, 75% had an increased serum creatinine above 
1.0 mg/dl and nearly 50% had anemia (hemoglobin in 
women <12 g/dl and in men <14 g/dl). Most patients’ 
urine showed leucocyturia suspicious for UTI (for details, 
see  table 3 ).
 Results of bacterial cultures from bladder or renal pel-
vis urine (sampled by ureter catheter or renal punction) 
or intraoperatively taken by swabs are shown in  table 3 . 
The main infecting agents were  E. coli and Proteus. Rou-
tine anaerobic cultures were not done.
 Sonography was the imaging method of first choice. 
Fifity-three out of fifty-seven obstructed kidneys (93%) 
were detected correctly (for details, see  table 3 ). In 2 out 
of the 57 (4%) OPN patients with nephrolithiasis, a tumor 
was suspected as a result of sonography and in 2 out of 57 
patients with staghorn calculus (4%), obstruction was not 
recognized. In 24 patients with suspected nephrolithiasis 
and in 1 with suspected pelvic tumor a plain radiograph 
was performed. Eighteen out of 24 stones (75%) could be 
found with this method. In 1/3 (n = 19) cases, sonography 
was supplemented by CT scans without contrast media. 
These detected 16/19 (84%) renal obstruction cases, 10/10 
(100%) tumors, and 8/9 (89%) urolithiasis.
 The family doctors’ initial diagnosis was correct as 
OPN in 34/57 cases (60%), ambiguous in 11/57 cases 
(19%), and wrong in 12/57 cases (21%) as confirmed dur-
ing inpatient investigation. The infection in 8/57 (14%) 
with ambiguous or wrong initial diagnosis and the ob-
struction in 20/57 (35%) were not diagnosed by the fam-
ily doctor. In 1/57 (2%) with OPN, the family doctor 
wrongly suspected a tumor.
Table 1.  Causes of obstruction in 57 patients with obstructive py-
elonephritis (OPN) or pyonephrosis
Causes Number Percentage
Urolithiasis 37 65
Pelvic and retroperitoneal tumors 12 21
Pregnancy 3 5
Iatrogenic lesions 2 4
Malformation 2 4
Neurogenic bladder after apoplex 1 2
Table 2.  Clinical symptoms in 57 patients with obstructive pyelo-
nephritis (OPN) or pyonephrosis
Symptoms Number Percentage
Fever 52 91
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Table 3. Laboratory changes, bacterial spectrum and imaging methods in 57 patients with obstructive pyelonephritis (OPN) or pyo-
nephrosis
a Laboratory changes
Laboratory findings Percentage Number
Leukocytosis 81 46
Increased blood sedimentation rate 16 9
Increased creatinine 75 43






Species Bladder urine culture RENAL pelvis urine/
intraoperative swab
E. coli 29 (51) 27 (47)
Proteus spp. 12 (21) 9 (16)
Staphylococcus spp. 8 (14) 7 (12)
Enterococcus faecalis 11 (19) 8 (14)
Streptococcus spp. 3 (5) 1 (2)
Klebsiella pneumoniae 3 (5) 4 (7)
Corynebacterium spp. 2 (4) 3 (5)
Citrobacter freundii 1 (2) 2 (2)
Pseudomonas aeruginosa 1 (2) 3 (5)
Morganella morganii 1 (2) 0 (0)
Mixed infection 16 (28) 9 (16)
Sterile 6 (11) 5 (9)
c Imaging
Procedure Diagnosis correct Diagnosis ambiguous Diagnosis wrong Not done
Sonography 53 (93) obstruction 2 (4) with staghorn calculus 2 (4) hypoechoic tumor 0
Plain abdomen radiograph 18 (72) urolithiasis
1 (4) no urolithiasis
0 6 (24) normal 32
Intravenous-urography 27 (84) obstruction or
renal insufficiency
1 (3) inactive kidney 4 (13) normal 25
Retrograde ureteropyelography 9 (100) obstruction 0 0 48
Computertomography 16 (84) OPN 3 (16) 1 semiliquid tumor,
2 lymphnodes or metastasis
due to carcinoma
0 38
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 Antibiotic Therapy 
 Twenty-five patients with OPN (44%) received antibi-
otic monotherapy (β-lactam antibiotics 21%, fluorquino-
lones 19%, co-trimoxazole 2%, aminoglycosides 2%); in 
32, (56%) combination therapy was used (aminoglyco-
side and β-lactam antibiotic 46%; fluoroquinolone and 
β-lactam antibiotic 5%; two β-lactam antibiotics 3%; ami-
noglycoside and tetracyclines 2%).
 Invasive Therapy 
 After the start of empiric antibiotic therapy, relief of 
renal obstruction and removal of infectious material were 
followed if necessary. Initial drainage was by percutane-
ous nephrostomy (81%) or ureteric stenting (19%) (for 
details, see  table 4 ). Eleven patients (19%) underwent ne-
phrectomy (8/37 with nephrolithiasis, 3/12 with tumors).
 In one patient with double kidney and ectopic ureter, 
heminephrectomy solved the problem. In one patient 
with a kidney stone and partial necrosis upper pole, par-
tial nephrectomy was performed.
 Follow-Up 
 During a follow-up of 1 to 5 years after successful OPN 
therapy, 18/57 patients (32%) showed recurrent UTI. In 
6/57 patients (11%), OPN recurred. Eight out of fifty-sev-
en patients (14%) died of the initially discovered tumor 
(8/12 – 67% of all patients with tumor), and 1 patient (2%) 
died of bronchopneumonia after 7 months. No fistula 
formation was reported. Follow-up of laboratory values 
was not done. Altogether, in this group of patients with 
OPN and without manifest urosepticemia at initial visit, 
no patient died due to OPN during a follow-up of 
1–5 years.
 Discussion 
 General Considerations 
 In general, men account only for 10–20% of all patients 
with UTI. The relative high occurrence rate of men (33%) 
with OPN in this study resulted from a high rate of uro-
lithiasis as underlying cause (37/57 – 65%). Men showed 
a higher stone incidence (from 1.3 up to 2.0) than did 
women  [8, 9] .
 Complicated upper urinary tract infections may occur 
in:
 (1) patients with no uropathic risk factors such as dia-
betes mellitus, postmenopause, renal insufficiency, or af-
ter renal transplantation;
 (2) patients with uropathies (anatomical or functional 
obstruction or foreign bodies in the urinary tract), which 
can be cured or improved (e.g., ureteral stents, temporary 
bladder catheter, vesicorenal reflux, or state after urolog-
ical intervention);
 (3) patients with permanent uropathies such as per-
manent catheter, stent or urinary diversion, or perma-
nent neurogenic bladder dysfunction.
 Patients in groups 2 and 3 are at risk for OPN. In our 
group, we did not find papillary necrosis, blood clots or 
fungus ball, tumor obstruction of the upper urinary 
tract, radiation therapy, bilharziosis, or tuberculosis as 
further causes of endoluminal OPN or tumor compres-
sion of the upper urinary tract and M. Ormond as fur-
ther causes of extrinsic OPN mentioned in the literature 
 [10, 11] .
 Symptoms and Clinical Signs 
 In immunocompromised patients, symptoms and 
clinical signs of OPN may be missing and only laboratory 
as well as sonographic findings will give the correct diag-
nosis. In 5.9–12.5%, bacteriuria may be missing due to 
completely obstructed ureter as in 9% of renal pelvic 
urine cultures and in 11% of bladder urine cultures in our 
patients  [7] .
 Tumors 
 OPN due to tumors, for example, in the pelvic region 
or bladder cancer, indicates locally advanced tumor state 
in many cases  [12] . This explains the high mortality rate 
(8/12 – 67%) in our patients with tumor-induced OPN 
during follow-up.
Table 4.  Invasive therapy in 57 patients with obstructive pyelo-
nephritis (OPN) or pyonephrosis
Procedure Number Percentage
Percutaneous nephrostomy 46 81
Ureteral stenting 11 19
Nephrectomy (8/37 with nephrolithiasis,
3/12 with tumors) 11 19
Partial nephrectomy 2 4
ESWL with nephrolithiasis 19 33
Ureterorenoscopy for urolithiasis 8 14
Chemolitholysis for uric acid stones 4 7
Percutaneous litholapaxy for urolithiasis 3 5
Zeiss sling for ureteral stone 3 5
Spontaneous passage of calculus 2 4
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 Diagnostic Methods 
 Aspirates from the obstructed kidney should be sent 
for culture and sensitivity analysis even after antibiotic 
therapy has started because of frequent discrepancy be-
tween urine and aspirate results due to the slow-rising 
antibiotic level within intrapelvic pus  [4, 11] . Compared 
with the lower value in our series (9%), Christoph et al. 
 [13] reported 46% sterile pelvic urine culture, presumably 
because of a higher rate of antibiotic pretreatment. The 
relatively low rate of  E. coli in our series is characteristic 
for complicated UTI, and the relatively high rate of Pro-
teus spp. is due to the high rate of infection stones, which 
was similar in the study of Ng et al.  [11] . The more diffi-
cult to treat bacteria such as Pseudomonas aeruginosa or 
even rarities such as Salmonella typhi may cause treat-
ment failure in primary calculated antibiotic therapy of 
OPN  [14, 15] . We agree with van Nieuwkoop et al.  [16] 
that imaging is necessary in patients with febrile UTI in 
the presence of a history of urolithiasis and/or a urine pH 
 ≥ 7.0 and/or renal insufficiency (estimated glomerular fil-
tration rate  ≤ 40 ml/min/1.73 m 3 ).
 Sonography in OPN may easily show dilation of the 
pelvicalyceal system. After changing the patient’s posi-
tion, there might be a change of the border fluid level be-
tween urine and pus, echogenic material in the whole py-
elocaliceal system, or gas with typical ultrasound shadows 
(also found in urinary stones). Thickening of the walls of 
the renal pelvis is another possible sign. An abnormal 
nephrogram with bulging of the renal contour in the set-
ting of hydronephrosis is also suggestive of the diagnosis. 
A normal sonography does not completely rule out renal 
obstruction, especially not in an early state. Bacterial tox-
ins may lead to calycopyelectasis without anatomical ob-
struction. Associated structures in the abdomen and pel-
vis can be imaged, which may reveal the cause or level of 
the obstruction  [2, 4, 5, 10, 17] .
 An i.v. urography is recommended only if CT scan is 
not available and may show reduced inflow of contrast 
media or a silent kidney. Care has to be taken not to give 
contrast media in renal insufficiency patients.
 During retrograde ureteropyelography after starting 
the antibiotic therapy, renal obstruction might be con-
firmed and resolved by double J stenting during one ses-
sion  [5] .
 CT is the investigation of choice in OPN not clearly 
diagnosed with sonography, as it depicts hydronephrosis 
and often the underlying cause  [4, 18] . Contrast-en-
hanced CT scan is more desirable, as parenchymal and 
functional changes due to infection can be assessed. CT 
scan confirms till 97% of ureteral or renal stones and 
100% of tumors  [4, 5, 17] . The same signs of OPN than in 
sonography might be demonstrated with a higher sensi-
tivity  [4, 10] . Pelvic wall thickening has a sensitivity of 
76% for pyonephrosis. Gas in the collecting system, in the 
absence of instrumentation, is the most accurate indica-
tor of presence of infected fluid. Parenchymal or parare-
nal gas would be signs of concomitant emphysematous 
pyelonephritis in OPN  [19] . Besides these findings, a stri-
ated nephrogram in the renal parenchyma as specific CT 
findings can occur in both pyonephrosis and obstructive 
pyelonephritis, although in pyonephrosis changes should 
be more severe. Contrast layer inversion representing 
contrast material overlying purulent fluid is rarely en-
countered  [4, 17] .
 Therapy 
 After starting empiric antibiotic therapy, relief of renal 
obstruction should be initiated immediately by either 
ureteral stenting or nephrostomy  [18] . Decompression of 
the system increases renal plasma flow and delivery of 
antibiotics to both parenchyma and urine  [4] . Both meth-
ods are equally effective  [20–22] . Nephrostomy eases 
controlling of urinary output and also pus may be extract-
ed from the renal pelvis by large volume nephrostomy 
much more easier than via a ureteral stent. Ureteral stent-
ing often needs to be performed in the operating room 
under general anesthesia, whereas nephrostomy can be 
performed under local anesthesia. Furthermore, there is 
the risk of perforating the ureter with stenting. In addi-
tion, bacteremia and septicemia may flare up under the 
pressure of the irrigation fluid. Nephrostomy cultures 
provide a higher microbiological detection rate than 
bladder urine cultures. Therefore, nephrostomy was used 
much more often in our study. A delay in renal decom-
pression or omitting it completely will increase the rate of 
sepsis and mortality  [2–4, 11, 23, 24] .
 After relief of renal obstruction, exacerbation of septi-
cemia may occur. In our series, since we had ruled out 
septicemia cases at the time of admission, we did not no-
tice this phenomenon  [5, 24] .
 After initial therapy and stabilization of the patient, 
definitive relief of renal obstruction (81% in our series) or 
nephrectomy of the kidneys without residual function 
(19% in our series) are indicated  [4] . Selected patients at 
a tertiary university center may explain the relatively low 
rate of 19% nephrectomies (11/57; 3/12 with malignan-
cies, 8/37 with Urolithiasis) in our series. This rate is sim-
ilar to the 12% nephrectomy rate reported by Ng et al. and 
a significant improvement from earlier studies, where the 
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 Early intervention in patients with OPN without signs 
of manifest urosepticemia prevented death due to the in-
fection in our series. Ng et al. reported a 2% death rate 
 [11] .
 Conclusions 
 Our data are the first showing a high OPN recurrence 
rate in adults with 11% and a high rate of UTI of 32% dur-
ing long-term follow-up after initial OPN-therapy. There-
fore, a regular long-term follow-up after acute OPN-ther-
apy and even low-dose antibiotic long-term prophylaxis 
should be discussed in adults, as some authors recommend 
it for children with upper urinary tract dilatation because 
of UTI rates between 4.3 and 36% during a 1-year follow-
up without prophylaxis  [25] . Because patients with tumors 
are followed anyhow, this recommendation is especially 
true for patients after acute OPN-therapy due to urolithia-
sis, malformations of the urinary tract, or other causes.
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